Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

abirateronacetat - filmsko obložena tableta - abirateronacetat 1000 mg / 1 tableta - abirateron

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

abirateronacetat - filmsko obložena tableta - abirateronacetat 500 mg / 1 tableta - abirateron

Evropska unija - slovenščina - EMA (European Medicines Agency)

janssen-cilag international n.v. - abiraterone acetate, niraparib tosilate monohydrate - prostatic neoplazem, kastracija-odporne - antineoplastična sredstva - treatment of adult patients with prostate cancer.

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

janssen-cilag international nv - abirateronacetat - filmsko obložena tableta - abirateronacetat 500 mg / 1 tableta - abirateron

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

abirateronacetat - filmsko obložena tableta - abirateronacetat 500 mg / 1 tableta

Evropska unija - slovenščina - EMA (European Medicines Agency)

accord healthcare s.l.u. - abirateron acetat - prostatične neoplazme - endokrini terapija - abiraterone accord is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicatedthe treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

abirateron - filmsko obložena tableta - abirateron 446,3 mg / 1 tableta - abirateron

Evropska unija - slovenščina - EMA (European Medicines Agency)

krka, d.d., novo mesto - abirateron acetat - prostatične neoplazme - endokrini terapija - abiraterone krka is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt) (see section 5. 1)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. 1)the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel-based chemotherapy regimen.

Evropska unija - slovenščina - EMA (European Medicines Agency)

mylan ireland limited - abirateron acetat - prostatične neoplazme - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

Evropska unija - slovenščina - EMA (European Medicines Agency)

janssen-cilag international n.v. - abirateron acetat - prostatične neoplazme - endokrini terapija - zytiga je označena z prednizon ali prednizolon za:zdravljenje metastatskega kastracije odporne raka na prostati pri odraslih moških, ki so asimptomatsko ali lahko simptomatsko po okvari androgen odvzem terapije, pri katerih kemoterapijo še ni klinično indicatedthe zdravljenje metastatskega kastracije odporne raka na prostati pri moških odraslih, katerih bolezen je napredovala na ali po docetaxel temelji kemoterapijo režim.